EGFRvIII, an oncogenic mutant of EGFR, is amplified in many glioblastoma multiforme (GBM) patients [53] and is transferred between glioma cells via membranous microvesicles (so-called oncosomes). This evidence concerns the gene EGFR and glioblastoma.